申请人:ARRAY BIOPHARMA, INC.
公开号:US20140142086A1
公开(公告)日:2014-05-22
Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
提供了对通过Toll样受体TLR7和/或TLR8信号传导进行调节的组合物和方法。这些组合物和方法在治疗或预防疾病方面有用,包括癌症、自身免疫疾病、传染病、炎症性疾病、移植排斥和移植物对宿主病。